Free shipping on all orders over $ 500

Synta66

Cat. No. M8747

All AbMole products are for research use only, cannot be used for human consumption.

Synta66 Structure
Size Price Availability Quantity
1mg USD 45  USD45 In stock
5mg USD 100  USD100 In stock
10mg USD 160  USD160 In stock
25mg USD 320  USD320 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Synta66 (S66) is a CRAC (Ca2+ release-activated Ca2+) channel inhibitor that blocks SOCE (store-operated Ca2+ entry) upon Ca2+ depletion from intracellular stores by thapsigargin in human vascular smooth muscle cells (VSMCs) with high potency (IC50 = 26 nM & 43 nM based on maximum Ca2+ level & rate of increase, respectly). Synta66 exhibits no affinity toward a range of receptors and ion channels (e.g. L-type Ca2+ channel) and does not affect TRPC1/5-mediated SOCE or store-operated non-selective cationic current. Leukocytes are reported to be less sensitive to CRAC inhibition by Synta66 (IC50 = 1.76 μM/HL-60, 1 μM/Jurkat, 1.4 μM/rat RBL).

Chemical Information
Molecular Weight 352.36
Formula C20H17FN2O3
CAS Number 835904-51-3
Form Solid
Solubility (25°C) DMSO: 20 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Shaswati Chaki, et al. Inhibition of Orai Channel Function Regulates Mas-Related G Protein-Coupled Receptor-Mediated Responses in Mast Cells

[2] Linda Waldherr, et al. Blockage of Store-Operated Ca 2+ Influx by Synta66 is Mediated by Direct Inhibition of the Ca 2+ Selective Orai1 Pore

[3] Xuexin Zhang, et al. Distinct pharmacological profiles of ORAI1, ORAI2, and ORAI3 channels

[4] Maki Kimura, et al. High pH-Sensitive Store-Operated Ca 2+ Entry Mediated by Ca 2+ Release-Activated Ca 2+ Channels in Rat Odontoblasts

[5] Roger van Kruchten, et al. Antithrombotic potential of blockers of store-operated calcium channels in platelets

Related Calcium Channel Products
CBD3063

CBD3063 is a selective, first-in-class, CRMP2-based peptidomimetic small molecule, which allosterically regulates Cav2.2 to achieve analgesia and pain relief without negative side effect profiles.

TTA-A8 

TTA-A8 is a short-acting T-type calcium channel antagonist with oral activity, exhibiting an IC50 value of 31.3 nM in the FLIPR depolarization assay.

MONIRO-1 

MONIRO-1 is a T-type and N-type calcium channel blocker with IC50 values of 34, 3.3, 1.7 and 7.2 µM against hCav2.2, hCav3.1, hCav3.2 and hCav3.3, respectively.

Azumolene

Azumolene (EU4093 free base), a Dantrolene analog, is a muscle relaxant.

Nexopamil 

Nexopamil is a calcium antagonist of Ca2+ channel, 5HT2, 5HT1A, 5HT1C and dopamine D2 receptors.

  Catalog
Abmole Inhibitor Catalog




Keywords: Synta66 supplier, Calcium Channel, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.